Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Smartleaf Asset Management LLC

Smartleaf Asset Management LLC boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 374.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 9,012 shares of the pharmacy operator’s stock after purchasing an additional 7,112 shares during the period. Smartleaf Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $83,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of WBA. State Street Corp grew its stake in shares of Walgreens Boots Alliance by 18.0% in the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after acquiring an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Walgreens Boots Alliance by 43.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after acquiring an additional 3,329,857 shares in the last quarter. Two Sigma Advisers LP acquired a new position in shares of Walgreens Boots Alliance in the third quarter worth $24,226,000. Thompson Siegel & Walmsley LLC grew its stake in shares of Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after acquiring an additional 934,754 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Walgreens Boots Alliance by 12.1% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after acquiring an additional 817,762 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Up 7.5 %

NASDAQ WBA opened at $11.39 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm has a market cap of $9.84 billion, a PE ratio of -1.11, a P/E/G ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $22.05. The firm’s fifty day moving average is $10.64 and its two-hundred day moving average is $9.72.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.66 earnings per share. Analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Evercore ISI lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Truist Financial decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Finally, Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $11.54.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.